COMPARISON OF THE CYCLOOXYGENASE-1 INHIBITORY PROPERTIES OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS (NSAIDS) AND SELECTIVE COX-2 INHIBITORS, USING SENSITIVE MICROSOMAL AND PLATELET ASSAYS

Two forms of cyclooxygenase (COX) activity are involved in the synthes is of prostaglandins, prostacyclins, and thromboxanes in mammalian cel ls. There is now convincing evidence, obtained with a number of struct urally distinct inhibitors, that selective COX-2 inhibitors possess an ti-inflammatory effects with an improved gastrointestinal tolerability compared with conventional nonsteroidal anti-inflammatory drugs (NSAI Ds) affecting both COX-1 and COX-2. As more selective COX-2 inhibitors are being developed, assays with a high degree of sensitivity to inhi bition are needed to compare the relative effects of compounds on COX- 1 activity. In the present report, we describe a sensitive assay for t he inhibition of human COX-1 based on the production of prostaglandin E-2 by microsomes from U937 cells incubated with a subsaturating conce ntration of arachidonic acid. More than 45 NSAIDs and selective COX-2 inhibitors were tested in this assay. IC50 values ranged from 1 nM for flunixin and flurbiprofen to about 200-500 mu M for salicylate and ac etaminophen. Potent and nonselective NSAIDs such as sulindac sulfide, diclofenac, and indomethacin showed IC50 values of <20 nM. Among the c ompounds that have been reported to show selectivity for COX-2, the ra nk order of potency against COX-1 was DuP 697 > SC-58451 > celecoxib > nimesulide similar to meloxicam similar to piroxicam similar to NS-39 8 similar to RS-57067 > SC-57666 > SC-58125 > flosulide > etodolac > L -745,337 > DFU similar to T-614, with IC50 values ranging from 7 nM to 17 mu M. A good correlation was obtained between the IC50 values for the inhibition of microsomal COX-1 and both the inhibition of TXB2 pro duction by Ca2+ ionophore challenged platelets and the inhibition of p rostaglandin E-2 production by CHO cells stably expressing human COX-1 . However, the microsomal assay was more sensitive to inhibition than cell-based assays and allowed the detection of inhibitory effects on C OX-1 for all NSAIDs and selective COX-2 inhibitors examined with discr imination of their potency under conditions of limited availability of arachidonic acid.